4 members of Congress have disclosed 6 trades in iShares Biotechnology ETF (IBB) since 2016: 2 purchases worth about $40.50K and 4 sales worth about $32.00K. The most active was David P. Joyce, with 2 trades. The latest trade was made on Feb 23, 2017.
IBB’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought IBB, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | David P. JoyceR-OH | 2 | 0 | 2 | $0.00 | $16.00K | -$16.00K | – | Feb 17, 2017 | Feb 23, 2017 |
| 2 | Richard L. HannaR-NY | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Dec 28, 2016 | Dec 28, 2016 |
| 3 | Carlos CurbeloR-FL | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | -126.2% | May 25, 2016 | Dec 30, 2016 |
| 4 | J. French HillR-AR | 1 | 1 | 0 | $32.50K | $0.00 | +$32.50K | -129.2% | May 31, 2016 | May 31, 2016 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| David P. JoyceR-OH | IBBiShares Nasdaq Biotechnology Index FundETF | Self | Sell | $1K–$15K | Feb 23, 2017 | May 8, 2019 | 804d late | +121.7% | -96.4% | |
| David P. JoyceR-OH | IBBiShares Nasdaq Biotechnology Index FundETF | Self | Sell | $1K–$15K | Feb 17, 2017 | Jul 26, 2017 | 159d late | +117.9% | -102.1% | |
| Richard L. HannaR-NY | IBBiShares Nasdaq Biotechnology Index FundETF | Self | Sell | $1K–$15K | Dec 28, 2016 | Jan 18, 2017 | 21d | +139.2% | -95.9% | |
| Carlos CurbeloR-FL | IBBiShares Nasdaq Biotechnology Index FundETF | Spouse | Sell | $1K–$15K | Dec 30, 2016 | Jan 10, 2017 | 11d | +141.7% | -94.8% | |
| J. French HillR-AR | IBBiShares Nasdaq Biotechnology Index FundETF | Self | Buy | $15K–$50K | May 31, 2016 | Jul 12, 2016 | 42d | +129.2% | -129.2% | |
| Carlos CurbeloR-FL | IBBiShAres Nasdaq Biotechnology Index FundETF | Spouse | Buy | $1K–$15K | May 25, 2016 | Jun 16, 2016 | 22d | +133.2% | -126.2% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
4 members of Congress have disclosed 6 trades in iShares Biotechnology ETF (IBB) since 2016: 2 purchases worth about $40.50K and 4 sales worth about $32.00K. The most active was David P. Joyce, with 2 trades. The latest trade was made on Feb 23, 2017. Most active: David P. Joyce (2), Richard L. Hanna (1), Carlos Curbelo (2), J. French Hill (1).
Since 2016 they have disclosed 2 purchases and 4 sales; by the midpoints of the disclosed ranges, about $40.50K bought and $32.00K sold, a net purchase of $8.50K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded IBB on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.